Reliability of Assessing Percentage of Diffusion-Perfusion Mismatch
Stroke 34:1681-1685, Coutts,S.B.,et al, 2003
Beyond Mismatch
Stroke 34:2729-2735, Kidwell,C.S.,et al, 2003
Best Measure of Ischemic Penumbra: Positron Emission Tomography
Stroke 34:2534-2535, Heiss,W.-D., 2003
Measurement of the Ischemic Penumbra With MRI: It's About Time
Stroke 34:2533-2534, Warach,S., 2003
Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion- Weighted Magnetic Resonance Imaging
Stroke 34:1892-1900, Thomalla,G.J.,et al, 2003
The Cortical Ischemic Core and Not the consistently Present Penumbra Is a Determinant of Cliniical Outcome in Acute Middle Cerebral Artery Occlusion
Stroke 34:24256-2435, Jovin,T.G.,et al, 2003
Predicting Cerebral Ischemic Infarct Volume with Diffusion and Perfusion MR Imaging
AJNR 23:1785-1794, Schaefer,P.W.,et al, 2002
Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002
Acute Intravenou-Intra-Arterial Revascularization Therapy for Severe Ischemic Stroke
Stroke 33:279-282, Hill,M.D.,et al, 2002
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke
Stroke 33:1437-1441, Ringleb,P.A.,et al, 2002
The Stroke Patient Who Woke Up
Stroke 33:988-993, Fink,J.N.,et al, 2002
Prognostic Accuracy of Cerebral Blood Flow Measurement by Perfusion Computed Tomography, at the Time of Emergency Room Admission, in Acute Stroke Patients
Ann Neurol 51:417-432,415, Wintermark,M.,et al, 2002
Comparison of Admission Perfusion Computed Tomography and Qualitative Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Acute Stroke Patients
Stroke 33:2025-2031, Wintermark,M.,et al, 2002
Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002
Fluid-Attenuated Inversion Recovery and Diffusion- and Perfusion-Weighted MRI Abnormalities in 117 Consecutive Patients with Stroke Symptoms
Stroke 32:2774-2781, Perkins,C.J.,et al, 2001
Is There an Apparent Diffusion Coefficient Threshold in Predicting Tissue Viability in Hyperacute Stroke?
Stroke 32:2486-2491,2460, Oppenheim,C.,et al, 2001
Diffusion-perfusion MRI Characterization of Post-recanalization Hyperperfusion in Humans
Neurol 57:2015-2021, Kidwell,C.S.,et al, 2001
Stroke Magnetic Resonance Imaging Within 6 Hours After Onset of Hyperacute Cerebral Ischemia
Ann Neurol 49:460-469, Schellinger,P.D.,et al, 2001
Diffusion- and Perfusion -Weighted Brain Magnetic Resonance Imaging in Patients with Neurologic Complications After Cardiac Surgery
Arch Neurol 58:571-576, Wityk,R.J.,et al, 2001
Acute Stroke Patterns in Patients With Internal Carotid Artery Disease
Stroke 32:1323-1329, Szabo,K.,et al, 2001
Relationship Between Magnetic Resonance Arterial Patency and Perfusion-Diffusion Mismatch in Acute Ischemic Stroke and Its Potential Clinical Use
Arch Neurol 58:1069-1074, Staroselskaya,I.A.,et al, 2001
Fluid-attenuated Inversion Recovery Intraarterial Signal: An Early Sign of Hyperacute Cerebral Ischemia
AJNR 22:1021-1029,1015, Toyoda,K.,et al, 2001
New Imaging Strategies for Patient Selection for Thrombolytic and Neuroprotective Therapies
Neurol 57:S48-S52, Warach,S., 2001
Intra-Arterial Thrombolysis
Neurol 57:S58-S60, Saver,J.L., 2001
Viability Thresholds of Ischemic Penumbra of Hyperacute Stroke Defined by Perfusion-Weighted MRI and Apparent Diffusion Coefficient
Stroke 32:1140-1146, Rohl,L.,et al, 2001
Thrombolytic Reversal of Acute Human Cerebral Ischemic Injury Shown by Diffusion/Perfusion Magnetic Resonance imaging
Ann Neurol 47:462-469, Kidwell,C.S.,et al, 2000
Feasibility and Practicality of MR Imaging of Stroke in the Management of Hyperacute Cerebral Ischemia
AJNR 21:1184-1189, 1177, Schellinger,P.D. et al, 2000
Combined Perfusion- and Diffusion-Weighted MR Imagng in Acute Ischemic Stroke Durng the 1st Week: A Longitudinal Study
Radiology 217:886-894, Karnoen,J.O.,et al, 2000
Dynamic CT Perfusion Imaging of Acute Stroke
AJNR 21:1441-1449, Mayer,T.E. et al, 2000
Ischemic Core and Penumbra in Human Stroke
Stroke 30:93-99, Kaufmann,A.M.,et al, 1999
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
Longitudinal Magnetic Resonance Imaging Study of Perfusion and Diffusion in Stroke:Evolution of Lesion Volume and Correlation with Clinical Outcome
Ann Neurol 46:568-578,556, Beaulieu,C.,et al, 1999
The Ischemic Penumbra,Operationally Defined by Diffusion and Perfusion MRI
Neurol 53:1528-1537, Schlaug,G.,et al, 1999
Prediction of Stroke Outcome with Echoplanar Perfusion-and Diffusion-Weighted MRI
Neurol 51:418-426, Barber,P.A.,et al, 1998
Duration of Neuroprotective Treatment for Ischemic Stroke
Stroke 29:535-542, Dyker,A.G.&Lees,K.R., 1998
Functional & Metabolic Analysis of Cerebral Ischemia Using Magnetoencephalography & Proton MR Spectroscopy
Ann Neurol 42:554-563, 5391997., Kamada,K.,et al, 1997
Characterizing the Target of Acute Stroke Therapy
Stroke 28:866-872, Fisher,M., 1997
Evolving Stroke and the Ischemic Penumbra
Neurol 47:884-888, Fisher,M.&Garcia,J.H., 1996
Spontaneous Neurological Recovery After Stroke and the Fate of the Ischemic Penumbra
Ann Neurol 40:216-226, Furlan,M.,et al, 1996
The Ischemic Penumbra, Injury Thresholds, and the Therapeutic Window for Acute Stroke
Ann Neurol 36:553-554, 5571994., Ginsberg,M.D.&Pulsinelli,W.A., 1994
MR Mismatch Is Useful for Patient Selection for Thrombolysis: No
Stroke 40:2908-2909,2910, Sch�bitz,W.R.,
Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025
Endovascular Therapy for Acute Vertebrobasilar Occlusion (VERITAS): A Systematic Review and Individual Patient Data Meta-Analysis
Lancet 405:61-69, Nogueira,R.G.,et al, 2025
Rocky Mountain Spotted Fever Encephalitis and "Starry Sky" Pattern on MRI, A Case Report
Neurologist 30:34-38, Mikhaiel,J.P.,et al, 2025
Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025
Atypical Presentation of HLA-B51 Positive Neuro-Bechet Disease in a 27-Year-Old Patient, The Waterfall Sign
Neurol 104:e210257, AbuAlrob,M.A., 2025
Distinguishing Transient Cerebral Ischemia From Other Brief Neurologic Events
Neurol 102:e208024, Warach,S. & Schellinger, P.D., 2024
The Optic Nerve Should Graduate to Be the Fifth Lesion Site for the Diagnosis of Multiple Sclerosis
Neurol 102:e207919, Galetta,S. & Brownlee, W., 2024
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy
Neurol 102:e208064, Wu, J.,et al, 2024